Cargando…

4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017 : ABC4 Consensus: Assessment by a Panel of German Experts

The fourth international advanced breast cancer consensus conference (ABC4) on the diagnosis and treatment of advanced breast cancer (ABC) headed by Professor Fatima Cardoso was once again held in Lisbon on November 2 – 4, 2017. To simplify matters, the abbreviation ABC will be used hereinafter in t...

Descripción completa

Detalles Bibliográficos
Autores principales: Untch, Michael, Würstlein, Rachel, Marschner, Norbert, Lüftner, Diana, Augustin, Doris, Briest, Susanne, Ettl, Johannes, Haidinger, Renate, Müller, Lothar, Müller, Volkmar, Ruckhäberle, Eugen, Harbeck, Nadia, Thomssen, Christoph
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Georg Thieme Verlag KG 2018
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986575/
https://www.ncbi.nlm.nih.gov/pubmed/29880982
http://dx.doi.org/10.1055/a-0594-2243
_version_ 1783328951867801600
author Untch, Michael
Würstlein, Rachel
Marschner, Norbert
Lüftner, Diana
Augustin, Doris
Briest, Susanne
Ettl, Johannes
Haidinger, Renate
Müller, Lothar
Müller, Volkmar
Ruckhäberle, Eugen
Harbeck, Nadia
Thomssen, Christoph
author_facet Untch, Michael
Würstlein, Rachel
Marschner, Norbert
Lüftner, Diana
Augustin, Doris
Briest, Susanne
Ettl, Johannes
Haidinger, Renate
Müller, Lothar
Müller, Volkmar
Ruckhäberle, Eugen
Harbeck, Nadia
Thomssen, Christoph
author_sort Untch, Michael
collection PubMed
description The fourth international advanced breast cancer consensus conference (ABC4) on the diagnosis and treatment of advanced breast cancer (ABC) headed by Professor Fatima Cardoso was once again held in Lisbon on November 2 – 4, 2017. To simplify matters, the abbreviation ABC will be used hereinafter in the text. In clinical practice, the abbreviation corresponds to metastatic breast cancer or locally far-advanced disease. This year the focus was on new developments in the treatment of ABC. Topics discussed included the importance of CDK4/6 inhibition in hormone receptor (HR)-positive ABC, the use of dual antibody blockade to treat HER2-positive ABC, PARP inhibition in triple-negative ABC and the potential therapeutic outcomes. Another major area discussed at the conference was BRCA-associated breast cancer, the treatment of cerebral metastasis, and individualized treatment decisions based on molecular testing (so-called precision medicine). As in previous years, close cooperation with representatives from patient organizations from around the world is an important aspect of the ABC conference. This cooperation was reinforced and expanded at the ABC4 conference. A global alliance was founded at the conclusion of the consensus conference, which aims to promote and coordinate the measures considered necessary by patient advocates worldwide. Because the panel of experts was composed of specialists from all over the world, it was inevitable that the ABC consensus also reflected country-specific features. As in previous years, a team of German breast cancer specialists who closely followed the consensus voting of the ABC panelists in Lisbon and intensively discussed the votes has therefore commented on the consensus in the context of the current German guidelines on the diagnosis and treatment of breast cancer 1 ,  2 used in clinical practice in Germany. The ABC consensus is based on the votes of the ABC panelists in Lisbon.
format Online
Article
Text
id pubmed-5986575
institution National Center for Biotechnology Information
language English
publishDate 2018
publisher Georg Thieme Verlag KG
record_format MEDLINE/PubMed
spelling pubmed-59865752018-06-05 4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017 : ABC4 Consensus: Assessment by a Panel of German Experts Untch, Michael Würstlein, Rachel Marschner, Norbert Lüftner, Diana Augustin, Doris Briest, Susanne Ettl, Johannes Haidinger, Renate Müller, Lothar Müller, Volkmar Ruckhäberle, Eugen Harbeck, Nadia Thomssen, Christoph Geburtshilfe Frauenheilkd The fourth international advanced breast cancer consensus conference (ABC4) on the diagnosis and treatment of advanced breast cancer (ABC) headed by Professor Fatima Cardoso was once again held in Lisbon on November 2 – 4, 2017. To simplify matters, the abbreviation ABC will be used hereinafter in the text. In clinical practice, the abbreviation corresponds to metastatic breast cancer or locally far-advanced disease. This year the focus was on new developments in the treatment of ABC. Topics discussed included the importance of CDK4/6 inhibition in hormone receptor (HR)-positive ABC, the use of dual antibody blockade to treat HER2-positive ABC, PARP inhibition in triple-negative ABC and the potential therapeutic outcomes. Another major area discussed at the conference was BRCA-associated breast cancer, the treatment of cerebral metastasis, and individualized treatment decisions based on molecular testing (so-called precision medicine). As in previous years, close cooperation with representatives from patient organizations from around the world is an important aspect of the ABC conference. This cooperation was reinforced and expanded at the ABC4 conference. A global alliance was founded at the conclusion of the consensus conference, which aims to promote and coordinate the measures considered necessary by patient advocates worldwide. Because the panel of experts was composed of specialists from all over the world, it was inevitable that the ABC consensus also reflected country-specific features. As in previous years, a team of German breast cancer specialists who closely followed the consensus voting of the ABC panelists in Lisbon and intensively discussed the votes has therefore commented on the consensus in the context of the current German guidelines on the diagnosis and treatment of breast cancer 1 ,  2 used in clinical practice in Germany. The ABC consensus is based on the votes of the ABC panelists in Lisbon. Georg Thieme Verlag KG 2018-05 2018-06-04 /pmc/articles/PMC5986575/ /pubmed/29880982 http://dx.doi.org/10.1055/a-0594-2243 Text en https://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivatives License, which permits unrestricted reproduction and distribution, for non-commercial purposes only; and use and reproduction, but not distribution, of adapted material for non-commercial purposes only, provided the original work is properly cited.
spellingShingle Untch, Michael
Würstlein, Rachel
Marschner, Norbert
Lüftner, Diana
Augustin, Doris
Briest, Susanne
Ettl, Johannes
Haidinger, Renate
Müller, Lothar
Müller, Volkmar
Ruckhäberle, Eugen
Harbeck, Nadia
Thomssen, Christoph
4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017 : ABC4 Consensus: Assessment by a Panel of German Experts
title 4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017 : ABC4 Consensus: Assessment by a Panel of German Experts
title_full 4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017 : ABC4 Consensus: Assessment by a Panel of German Experts
title_fullStr 4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017 : ABC4 Consensus: Assessment by a Panel of German Experts
title_full_unstemmed 4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017 : ABC4 Consensus: Assessment by a Panel of German Experts
title_short 4th International Consensus Conference on Advanced Breast Cancer (ABC4), Lisbon, November 4, 2017 : ABC4 Consensus: Assessment by a Panel of German Experts
title_sort 4th international consensus conference on advanced breast cancer (abc4), lisbon, november 4, 2017 : abc4 consensus: assessment by a panel of german experts
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5986575/
https://www.ncbi.nlm.nih.gov/pubmed/29880982
http://dx.doi.org/10.1055/a-0594-2243
work_keys_str_mv AT untchmichael 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts
AT wurstleinrachel 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts
AT marschnernorbert 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts
AT luftnerdiana 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts
AT augustindoris 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts
AT briestsusanne 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts
AT ettljohannes 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts
AT haidingerrenate 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts
AT mullerlothar 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts
AT mullervolkmar 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts
AT ruckhaberleeugen 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts
AT harbecknadia 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts
AT thomssenchristoph 4thinternationalconsensusconferenceonadvancedbreastcancerabc4lisbonnovember42017abc4consensusassessmentbyapanelofgermanexperts